Scarica l'app Stockscreener
0.6644
5.00%
-0.035
Dopo l'orario di chiusura:
.67
0.0056
+0.84%
Precedente Chiudi:
$0.6994
Aprire:
$0.671
Volume 24 ore:
598.72K
Relative Volume:
0.61
Capitalizzazione di mercato:
$39.01M
Reddito:
-
Utile/perdita netta:
$-123.46M
Rapporto P/E:
-0.2565
EPS:
-2.59
Flusso di cassa netto:
$-104.11M
1 W Prestazione:
-5.99%
1M Prestazione:
-4.24%
6M Prestazione:
+19.07%
1 anno Prestazione:
-68.21%
Intervallo 1D:
$0.6501
$0.72
Intervallo di 1 settimana:
$0.6501
$0.7579
Portata 52W:
$0.2601
$2.525
Bioatla Inc Stock (BCAB) Company Profile
Nome
Bioatla Inc
Settore
Industria
Telefono
858-558-0708
Indirizzo
11085 TORREYANA ROAD, SAN DIEGO
Confronta BCAB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BCAB
Bioatla Inc
|
0.6644 | 41.07M | 0 | -123.46M | -104.11M | -2.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Bioatla Inc Stock (BCAB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-13 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-11-13 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-09-15 | Iniziato | JMP Securities | Mkt Outperform |
| 2022-05-05 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-03-21 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-15 | Ripresa | BTIG Research | Buy |
| 2021-06-28 | Iniziato | ROTH Capital | Buy |
| 2021-05-05 | Ripresa | Credit Suisse | Outperform |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2021-01-11 | Iniziato | BTIG Research | Buy |
| 2021-01-11 | Iniziato | Credit Suisse | Outperform |
| 2021-01-11 | Iniziato | JP Morgan | Overweight |
| 2021-01-11 | Iniziato | Jefferies | Buy |
Mostra tutto
Bioatla Inc Borsa (BCAB) Ultime notizie
Is BioAtla Inc. a candidate for recovery playPortfolio Growth Summary & Weekly Chart Analysis and Trade Guides - newser.com
Analyzing BioAtla Inc. with multi timeframe chartsEarnings Risk Summary & Daily Technical Forecast Reports - newser.com
Will BioAtla Inc. continue its uptrend2025 Winners & Losers & Real-Time Buy Signal Alerts - newser.com
Why BioAtla Inc. stock is favored by top institutions2025 Technical Patterns & High Yield Stock Recommendations - newser.com
Analyzing BioAtla Inc. with risk reward ratio chartsJuly 2025 Pullbacks & Reliable Breakout Forecasts - newser.com
Sentiment analysis tools applied to BioAtla Inc.Quarterly Profit Summary & Weekly Top Performers Watchlists - newser.com
Regression analysis insights on BioAtla Inc. performanceEarnings Growth Report & Safe Capital Growth Tips - newser.com
What to do if you’re stuck in BioAtla Inc.Quarterly Market Review & Long Hold Capital Preservation Plans - newser.com
Measuring BioAtla Inc.’s beta against major indicesJuly 2025 Patterns & Intraday High Probability Setup Alerts - newser.com
BioAtla, Inc. (BCAB) stock forecast and price target - Yahoo! Finance UK
How supply chain issues affect BioAtla Inc. stockJuly 2025 Spike Watch & Weekly Market Pulse Alerts - newser.com
Chart overlay techniques for tracking BioAtla Inc.Quarterly Growth Report & Stock Timing and Entry Methods - newser.com
BioAtla, Inc. (BCAB) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
What moving averages say about BioAtla Inc.Bond Market & Capital Efficiency Focused Ideas - newser.com
BioAtla’s Phase 1 Study on BA3182: A New Hope for Advanced Adenocarcinoma - MSN
BioAtla (BCAB) to Release Quarterly Earnings on Thursday - Defense World
BioAtla Stock Lost 7.0%, Buy Or Wait? - Trefis
Why BioAtla Inc. stock is a value investor pickWeekly Risk Summary & Advanced Technical Signal Analysis - fcp.pa.gov.br
Bioatla Inc Azioni (BCAB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.64%
0.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):